Skip to main content
Erschienen in: Molecular Diagnosis & Therapy 1/2009

01.03.2009 | Short Communication

HIV-1 with Predicted CXCR4 Genotype Identified in Clade C from India

verfasst von: Abraham Joseph Kandathil, Prof. Rajesh Kannangai, Oriapadickal Cherian Abraham, Susanne Alexander Pulimood, Mark A. Jensen, Gopalan Sridharan

Erschienen in: Molecular Diagnosis & Therapy | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Background and objective: HIV-1 uses co-receptors CCR5 and CXCR4 in addition to CD4 for viral entry into cells. CCR5 is used in the early stages of HIV-1 infection, but viruses that utilize CXCR4 for viral entry emerge in the later stages. This is not common among clade C strains, with previous data from India showing the absence of the emergence of CXCR4-using strains. Sequence analysis has demonstrated that the V3 loop plays a very important role in determining the syncytium-inducing (SI) phenotype. The V3 region of the SI variants were observed to have positively charged amino acids at positions 11 and/or 25 and also a overall higher charge. This study looked at co-receptor usage among HIV-1 strains in India from individuals who were antiretroviral therapy (ART) naïve and those not responding to ART.
Methods: Amplification and sequencing of the HIV-1 env gp120 V3 region was done on 40 ART-naïve individuals, who were selected for the study based on their CD4 counts, and eight patients who had not responded to ART. The sequences were submitted to Geno2Pheno and Web PSSM. The pol gene sequences of these strains were submitted to the REGA HIV-1 subtyping tool.
Results: Forty-seven strains were identified as clade C and one strain as clade A1. Geno2Pheno identified three CXCR4-using strains, and the Web PSSM clade C matrix identified two.
Conclusion: We report, for the first time, CXCR4-using strains among HIV-1 clade C strains circulating in India.
Literatur
1.
Zurück zum Zitat Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17: 657–700PubMedCrossRef Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17: 657–700PubMedCrossRef
2.
Zurück zum Zitat Koot M, Keet IP, Vos AH, et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993; 118: 681–8PubMed Koot M, Keet IP, Vos AH, et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993; 118: 681–8PubMed
3.
Zurück zum Zitat Koot M, Vos AH, Keet RP, et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992; 6: 49–54PubMedCrossRef Koot M, Vos AH, Keet RP, et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992; 6: 49–54PubMedCrossRef
4.
Zurück zum Zitat Ping LH, Nelson JA, Hoffman IF, et al. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol 1999; 73: 6271–81PubMed Ping LH, Nelson JA, Hoffman IF, et al. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol 1999; 73: 6271–81PubMed
5.
Zurück zum Zitat Cecilia D, Kulkarni SS, Tripathy SP, et al. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 2000; 271: 253–8PubMedCrossRef Cecilia D, Kulkarni SS, Tripathy SP, et al. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 2000; 271: 253–8PubMedCrossRef
6.
Zurück zum Zitat Connell BJ, Michler K, Capovilla A, et al. Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa. AIDS 2008; 22: 896–9PubMedCrossRef Connell BJ, Michler K, Capovilla A, et al. Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa. AIDS 2008; 22: 896–9PubMedCrossRef
7.
Zurück zum Zitat Mueller MC, Bogner JR. Treatment with CCR5 antagonists: which patient may have a benefit? Eur J Med Res 2007; 12: 441–52PubMed Mueller MC, Bogner JR. Treatment with CCR5 antagonists: which patient may have a benefit? Eur J Med Res 2007; 12: 441–52PubMed
8.
Zurück zum Zitat Freed EO, Martin MA. HIVs and their replication. In: eiKnipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins 2001; 1971–2042 Freed EO, Martin MA. HIVs and their replication. In: eiKnipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins 2001; 1971–2042
9.
Zurück zum Zitat Jensen MA, van’t Wout AB. Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 2003; 5: 104–12PubMed Jensen MA, van’t Wout AB. Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 2003; 5: 104–12PubMed
10.
Zurück zum Zitat Kandathil AJ, Kannangai R, David S, et al. CD4+ and CD8+ T cell estimation by a micro-capillary cytometry technology compared with flow cytometry. Clin Diagn Lab Immunol 2005; 12: 1006–9PubMed Kandathil AJ, Kannangai R, David S, et al. CD4+ and CD8+ T cell estimation by a micro-capillary cytometry technology compared with flow cytometry. Clin Diagn Lab Immunol 2005; 12: 1006–9PubMed
11.
Zurück zum Zitat Kannangai R, Kandathil AJ, Ebenezer DL, et al. Evidence for lower CD4+ T cell and higher viral load in asymptomatic HIV-1 infected individuals of India (south): implications for therapy initiation. Indian J Med Microbiol 2008; 26: 217–21PubMedCrossRef Kannangai R, Kandathil AJ, Ebenezer DL, et al. Evidence for lower CD4+ T cell and higher viral load in asymptomatic HIV-1 infected individuals of India (south): implications for therapy initiation. Indian J Med Microbiol 2008; 26: 217–21PubMedCrossRef
13.
Zurück zum Zitat 13. Nomenclature for incompletely specified bases in nucleic acid sequences: recommendations 1984. Nomenclature Committee of the International Union of Biochemistry (NC-IUB). Proc Natl Acad Sci U S A 1986; 83: 4–8CrossRef 13. Nomenclature for incompletely specified bases in nucleic acid sequences: recommendations 1984. Nomenclature Committee of the International Union of Biochemistry (NC-IUB). Proc Natl Acad Sci U S A 1986; 83: 4–8CrossRef
15.
Zurück zum Zitat Geno2pheno (coreceptor) [computer program; online]. Available from URL: [http://co-receptor.bioinf.mpi-inf.mpg.de/index.php] [Accessed 2008 Apr 23] Geno2pheno (coreceptor) [computer program; online]. Available from URL: [http://​co-receptor.​bioinf.​mpi-inf.​mpg.​de/​index.​php] [Accessed 2008 Apr 23]
18.
Zurück zum Zitat Crooks GE, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Research 2004; 14: 1188–90PubMedCrossRef Crooks GE, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Research 2004; 14: 1188–90PubMedCrossRef
19.
Zurück zum Zitat Kandathil AJ, Kannangai R, Abraham OC, et al. The frequency of HIV-I drug resistance mutations among treatment naïve individuals at a tertiary care centre in south India. Int J STD & AIDS. In press Kandathil AJ, Kannangai R, Abraham OC, et al. The frequency of HIV-I drug resistance mutations among treatment naïve individuals at a tertiary care centre in south India. Int J STD & AIDS. In press
21.
Zurück zum Zitat Tamura K, Dudley J, Nei M, et al. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596–9PubMedCrossRef Tamura K, Dudley J, Nei M, et al. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596–9PubMedCrossRef
23.
Zurück zum Zitat Jensen MA, Coetzer M, van’t Wout AB, et al. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J Virol 2006; 80: 4698–704PubMedCrossRef Jensen MA, Coetzer M, van’t Wout AB, et al. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J Virol 2006; 80: 4698–704PubMedCrossRef
24.
Zurück zum Zitat Garrido C, Roulet V, Chuecaau N, et al. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes. J Clin Microbiol 2008; 46: 887–91PubMedCrossRef Garrido C, Roulet V, Chuecaau N, et al. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes. J Clin Microbiol 2008; 46: 887–91PubMedCrossRef
25.
Zurück zum Zitat Westby M, Lewis M, Whitcomb J, et al. Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir. J Virol 2006; 80: 4909–20PubMedCrossRef Westby M, Lewis M, Whitcomb J, et al. Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir. J Virol 2006; 80: 4909–20PubMedCrossRef
Metadaten
Titel
HIV-1 with Predicted CXCR4 Genotype Identified in Clade C from India
verfasst von
Abraham Joseph Kandathil
Prof. Rajesh Kannangai
Oriapadickal Cherian Abraham
Susanne Alexander Pulimood
Mark A. Jensen
Gopalan Sridharan
Publikationsdatum
01.03.2009
Verlag
Springer International Publishing
Erschienen in
Molecular Diagnosis & Therapy / Ausgabe 1/2009
Print ISSN: 1177-1062
Elektronische ISSN: 1179-2000
DOI
https://doi.org/10.1007/BF03256311

Weitere Artikel der Ausgabe 1/2009

Molecular Diagnosis & Therapy 1/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.